Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00218504 · ClinicalTrials.gov registry record
Responses to Marijuana-Related Cues Versus Neutral Cues in Adults Taking Tetrahydrocannabinol (THC) - 2
A clinical trial, sponsored by Wayne State University.
- Completed
- Registry status
- 20
- Enrollment target
NCT00218504 is a clinical trial that has completed, run by Wayne State University. The registered enrollment target is 20 participants.
The verdict
NCT00218504 has completed, sponsored by Wayne State University.
- COMPLETED
- Registry status
- 20 participants
- Enrollment target
Study Summary
The majority of past research on marijuana treatment has targeted the alleviation of withdrawal symptoms. Minimal focus has been placed on how altering craving effects may play a role in treating marijuana addiction. Treatment with tetrahydrocannabinol (THC), the main ingredient in marijuana responsible for its reinforcing effects, may decrease marijuana cravings. The purpose of this study is to evaluate the effect of THC pre-treatment on responses to marijuana-related cues versus non marijuana-related cues in individuals addicted to marijuana.
Interventions
- DRUG Tetrahydrocannabinol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2005-12 |
| Est. Completion | 2009-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00218504
The ClinicalTrials.gov registry entry for NCT00218504 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wayne State University, which has 163 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Tetrahydrocannabinol is the first listed.
NCT00218504 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00218504 about?
NCT00218504 is a clinical study titled "Responses to Marijuana-Related Cues Versus Neutral Cues in Adults Taking Tetrahydrocannabinol (THC) - 2". The majority of past research on marijuana treatment has targeted the alleviation of withdrawal symptoms. Minimal focus has been placed on how altering craving effects may play a role in treating marijuana addiction. Treatment with tetrahydrocannabinol (THC), the main ingredient in marijuana respons...
What is the current status of trial NCT00218504?
This trial is currently completed. The enrollment target is 20 participants. The study started on 2005-12. Estimated completion is 2009-10.
What interventions are being tested in trial NCT00218504?
The interventions under investigation include: Tetrahydrocannabinol (DRUG).
Who is sponsoring clinical trial NCT00218504?
This trial is sponsored by Wayne State University, which has 163 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.